Oak Family Advisors’s CONMED CNMD Stock Holding History

Oak Family Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,116	Closed	-$213K	–	117
2024 Q4	$213K	Sell	3,116 -7,237	-70%	-$504K	0.08%	108
2024 Q3	$745K	Sell	10,353 -146	-1%	-$10.3K	0.23%	76
2024 Q2	$728K	Buy	10,499 +2,548	+32%	+$186K	0.25%	75
2024 Q1	$637K	Buy	7,951 +1,401	+21%	+$125K	0.24%	75
2023 Q4	$717K	Buy	6,550 +2	+0%	+$207	0.3%	71
2023 Q3	$660K	Hold	6,548	–	–	0.31%	64
2023 Q2	$890K	Sell	6,548 -247	-4%	-$30.2K	0.42%	53
2023 Q1	$706K	Sell	6,795 -1	-0%	-$97	0.35%	60
2022 Q4	$602K	Buy	6,796 +1,332	+24%	+$111K	0.32%	66
2022 Q3	$438K	Buy	5,464 +2,873	+111%	+$271K	0.23%	70
2022 Q2	$248K	Hold	2,591	–	–	0.12%	107
2022 Q1	$385K	Hold	2,591	–	–	0.15%	94
2021 Q4	$367K	Sell	2,591 -57	-2%	-$8.07K	0.14%	101
2021 Q3	$346K	Buy	+2,648	New	+$346K	0.13%	101

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Oak Family Advisors's CNMD Position: Q1 2025 in Review

Oak Family Advisors sold out of CONMED (CNMD) in Q1 2025, closing a stake of 3,116 shares — an estimated $213K sold.

Oak Family Advisors first reported a position in CNMD in Q3 2021 and held it in 14 quarters. The position peaked at $890K in Q2 2023. 280 funds tracked by Wall St. Rank hold CNMD as of Q1 2025.

Oak Family Advisors reported no remaining CONMED position as of Q1 2025 after selling out during the quarter.
Oak Family Advisors sold 3,116 CONMED shares in Q1 2025, an estimated $213K.
Oak Family Advisors first reported a position in CONMED in Q3 2021 and held it in 14 quarters.
Oak Family Advisors's CONMED position peaked at $890K in Q2 2023.
280 funds tracked by Wall St. Rank held CONMED as of Q1 2025.

Based on Oak Family Advisors's 13F filing for Q1 2025, filed 15 Apr 2025.